questionsmedicales.fr
Maladies endocriniennes
Maladies de la thyroïde
Hyperthyroïdie
Hyperthyroïdie : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperthyroïdie : Questions médicales les plus fréquentes",
"headline": "Hyperthyroïdie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperthyroïdie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperthyroïdie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies de la thyroïde",
"url": "https://questionsmedicales.fr/mesh/D013959",
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la thyroïde",
"code": {
"@type": "MedicalCode",
"code": "D013959",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.874"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thyréotoxicose",
"alternateName": "Thyrotoxicosis",
"url": "https://questionsmedicales.fr/mesh/D013971",
"about": {
"@type": "MedicalCondition",
"name": "Thyréotoxicose",
"code": {
"@type": "MedicalCode",
"code": "D013971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.874.397.685"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Crise thyréotoxique",
"alternateName": "Thyroid Crisis",
"url": "https://questionsmedicales.fr/mesh/D013958",
"about": {
"@type": "MedicalCondition",
"name": "Crise thyréotoxique",
"code": {
"@type": "MedicalCode",
"code": "D013958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.874.397.685.905"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hyperthyroïdie",
"alternateName": "Hyperthyroidism",
"code": {
"@type": "MedicalCode",
"code": "D006980",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "M Trebillod",
"url": "https://questionsmedicales.fr/author/M%20Trebillod",
"affiliation": {
"@type": "Organization",
"name": "Service d'Endocrinologie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "P Pétrossians",
"url": "https://questionsmedicales.fr/author/P%20P%C3%A9trossians",
"affiliation": {
"@type": "Organization",
"name": "Service d'Endocrinologie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "Priya Vaidyanathan",
"url": "https://questionsmedicales.fr/author/Priya%20Vaidyanathan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Endocrinology, Children's National Hospital, Washington, DC 20010, USA. Electronic address: pvaidyan@childrensnational.org."
}
},
{
"@type": "Person",
"name": "David L Panciera",
"url": "https://questionsmedicales.fr/author/David%20L%20Panciera",
"affiliation": {
"@type": "Organization",
"name": "Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA."
}
},
{
"@type": "Person",
"name": "Katie M Boes",
"url": "https://questionsmedicales.fr/author/Katie%20M%20Boes",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences & Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer.",
"datePublished": "2023-06-27",
"url": "https://questionsmedicales.fr/article/37370088",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12920-023-01571-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "VDAC genes down-regulation in brain samples of individuals with schizophrenia is revealed by a systematic meta-analysis.",
"datePublished": "2023-01-27",
"url": "https://questionsmedicales.fr/article/36717018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neures.2023.01.012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reduced virulence in tigecycline-resistant Klebsiella pneumoniae caused by overexpression of ompR and down-regulation of ompK35.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37004036",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12929-023-00910-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Down-regulation of autophagy proteins is associated with higher mTOR expression in the placenta of pregnant women with preeclampsia.",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36629523",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1414-431X2022e12283"
}
},
{
"@type": "ScholarlyArticle",
"name": "Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.",
"datePublished": "2022-10-22",
"url": "https://questionsmedicales.fr/article/36273122",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s11658-022-00388-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la thyroïde",
"item": "https://questionsmedicales.fr/mesh/D013959"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hyperthyroïdie",
"item": "https://questionsmedicales.fr/mesh/D006980"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperthyroïdie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperthyroïdie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperthyroïdie",
"description": "Comment diagnostiquer l'hyperthyroïdie ?\nQuels examens sont utilisés pour confirmer l'hyperthyroïdie ?\nQuels symptômes indiquent une hyperthyroïdie ?\nQuel rôle joue la TSH dans le diagnostic ?\nPeut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Down-Regulation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperthyroïdie",
"description": "Quels sont les symptômes courants de l'hyperthyroïdie ?\nL'hyperthyroïdie cause-t-elle des problèmes de sommeil ?\nComment l'hyperthyroïdie affecte-t-elle le poids ?\nY a-t-il des symptômes oculaires associés ?\nL'hyperthyroïdie peut-elle causer des palpitations ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Down-Regulation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperthyroïdie",
"description": "Peut-on prévenir l'hyperthyroïdie ?\nLes antécédents familiaux influencent-ils le risque ?\nLe stress peut-il déclencher l'hyperthyroïdie ?\nUne alimentation équilibrée aide-t-elle ?\nLes carences en iode sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Down-Regulation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperthyroïdie",
"description": "Quels traitements existent pour l'hyperthyroïdie ?\nComment fonctionnent les médicaments antithyroïdiens ?\nQuand est-ce que la chirurgie est nécessaire ?\nL'iode radioactif est-il un traitement efficace ?\nQuels effets secondaires peuvent avoir les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Down-Regulation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperthyroïdie",
"description": "Quelles sont les complications de l'hyperthyroïdie ?\nL'hyperthyroïdie peut-elle causer des problèmes cardiaques ?\nQu'est-ce qu'une crise thyroïdienne ?\nComment l'hyperthyroïdie affecte-t-elle les os ?\nY a-t-il des risques de complications psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Down-Regulation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperthyroïdie",
"description": "Quels sont les principaux facteurs de risque ?\nLe sexe influence-t-il le risque d'hyperthyroïdie ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes traitements antérieurs de la thyroïde augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006980?mesh_terms=Down-Regulation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperthyroïdie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des tests sanguins mesurant les niveaux de TSH et T4 libre."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour confirmer l'hyperthyroïdie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des scintigraphies thyroïdiennes et des échographies peuvent être réalisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hyperthyroïdie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent perte de poids, nervosité, palpitations et insomnie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la TSH dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une TSH basse indique souvent une hyperthyroïdie, car la thyroïde est hyperactive."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'hyperthyroïdie par des symptômes seuls ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes doivent être confirmés par des tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'hyperthyroïdie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, irritabilité, tremblements et transpiration excessive."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie cause-t-elle des problèmes de sommeil ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des insomnies et des troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle le poids ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle provoque souvent une perte de poids malgré un appétit accru."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes oculaires associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes oculaires comme l'exophtalmie peuvent survenir."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie peut-elle causer des palpitations ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les palpitations cardiaques sont un symptôme fréquent."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hyperthyroïdie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier aide."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de maladies thyroïdiennes augmente le risque."
}
},
{
"@type": "Question",
"name": "Le stress peut-il déclencher l'hyperthyroïdie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut aggraver les symptômes, mais n'est pas une cause directe."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée aide-t-elle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé thyroïdienne, mais ne prévient pas l'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "Les carences en iode sont-elles un facteur de risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'excès d'iode est plus souvent lié à l'hyperthyroïdie que la carence."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour l'hyperthyroïdie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les médicaments antithyroïdiens, l'iode radioactif et la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les médicaments antithyroïdiens ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la production d'hormones thyroïdiennes par la glande thyroïde."
}
},
{
"@type": "Question",
"name": "Quand est-ce que la chirurgie est nécessaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si les autres traitements échouent ou en cas de goitre volumineux."
}
},
{
"@type": "Question",
"name": "L'iode radioactif est-il un traitement efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent utilisé pour détruire les cellules thyroïdiennes hyperactives."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent avoir les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des éruptions cutanées, des douleurs articulaires et des troubles hépatiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hyperthyroïdie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes cardiaques, l'ostéoporose et la crise thyroïdienne."
}
},
{
"@type": "Question",
"name": "L'hyperthyroïdie peut-elle causer des problèmes cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des arythmies et une insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une crise thyroïdienne ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une urgence médicale avec une augmentation soudaine des hormones thyroïdiennes."
}
},
{
"@type": "Question",
"name": "Comment l'hyperthyroïdie affecte-t-elle les os ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une diminution de la densité osseuse, augmentant le risque d'ostéoporose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications psychologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperthyroïdie peut provoquer anxiété et dépression chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de maladies thyroïdiennes."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque d'hyperthyroïdie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer une hyperthyroïdie que les hommes."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie de Graves augmentent le risque d'hyperthyroïdie."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 60 ans."
}
},
{
"@type": "Question",
"name": "Les traitements antérieurs de la thyroïde augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements comme la radiothérapie peuvent augmenter le risque d'hyperthyroïdie."
}
}
]
}
]
}
The human genome encodes more than 350 kinds of Krüppel-associated box (KRAB) domain-containing zinc-finger proteins (KZFPs), KRAB-type ZNF transcription factor family (KZNF) plays a vital role in gen...
Mitochondrial dysfunction was shown to be involved in schizophrenia pathophysiology. Abnormal energy states can lead to alterations in neural function and thereby to the cognitive and behavioral aberr...
The development of tigecycline resistance in hypervirulent Klebsiella pneumoniae strains has resulted in decreased virulence that is associated with reduced production of capsular polysaccharides (CPS...
We compared transcriptomes from tigecycline-susceptible wild-type strains and tigecycline-resistant mutants using mRNA sequencing. ompR-overexpressed and ompR-deleted mutants were constructed from wil...
Transcriptomic analyses demonstrated a significant decrease in the expression of ompK35 in the tigecycline-resistant mutants. We observed that tigecycline-resistant mutants overexpressed ompR, and tha...
In hypervirulent K. pneumoniae strains, ompR expression, which is regulated by exposure to tigecycline, may affect the production of CPS, leading to bacterial virulence....
Autophagy is a lysosomal degradation pathway that removes protein aggregates and damaged organelles maintaining cellular integrity. It seems to be essential for cell survival during stress, starvation...
EVA1A (Eva-1 homolog A), a novel protein involved in autophagy and apoptosis, functions as a tumor suppressor in some human primary cancers, including hepatocellular carcinoma (HCC). While it is consi...
We first detected the expression of EVA1A in HCC tissues and cell lines using RT‒qPCR, immunohistochemistry and western blotting and detected the expression of miR-103a-3p by RT‒qPCR. Then, bioinforma...
We found that EVA1A expression was decreased while miR-103a-3p expression was increased in HCC tissues and cell lines and that their expression was inversely correlated in HCC patients. The expression...
These findings indicate that the downregulation of the tumor suppressor EVA1A by miR-103a-3p potentially acts as a key mediator in HCC progression, mainly by inhibiting apoptosis and promoting metasta...
Long non-coding RNAs (lncRNAs) have been widely used in the exploration of diseases in recent years. This paper introduced the significance of lncRNA LINC00324 (LINC00324) on the progression of cervic...
The cervical cancer tissues and adjacent normal tissues of 120 people were collected as research samples. The expression level of LINC00324 was assessed by RT-qPCR, as was miR-195-5p. Knockdown of LIN...
Significantly increased expression of LINC00324 and down-regulated miR-195-5p were negatively correlated in cervical cancer. Knockdown of LINC00324 inhibited the progression of cervical cancer, which ...
LINC00324 targets miR-195-5p to regulate the progression of cervical cancer and have potential as a prognostic molecular marker for cervical cancer....
The floral volatile profile of Petunia x hybrida 'Mitchell diploid' (MD) is dominated by phenylpropanoids, many of which are derived from p-coumaric acid. However, the downstream processes involved in...
Lowered CSE transcript accumulation in ir-PhCSE plants resulted in reduced lignin layers in the stems and stunted growth, suggesting a positive correlation between lignin layers and lignin content. Th...
Reduced lignin layers in the stems and stunted growth in ir-PhCSE plants suggest that PhCSE is essential for lignin production and plant growth in petunia. The decreased CSE level influenced the expre...
Paclitaxel (PTX) is an anti-microtubule agent, used for the treatment of various types of cancers; however, it produces painful neuropathy which limits its use. Many neuroprotective agents have been i...
Prostate cancer (PCa) is the most common cancer among men in the United States and the leading cause of cancer-related death. The Solute Carrier Family 14 Member 1 (SLC14A1) is a member of urea transp...
Venturia inaequalis is an apple scab causing fungal pathogen. It is a highly contagious and destructive pathogen which rapidly spreads infection in the surrounding orchards if not managed. The managem...
The exogenous application of dsRNAs was found to reduce mycelial growth and spore formation of V. inaequalis on culture plates. Four genes of V. inaequalis viz. CIN1, CE5, VICE12 and VICE16 which get ...
The result of this investigation validates the hypothesis that RNAi is evoked in V. inaequalis by exogenously supplied dsRNA and spray induced gene silencing (SIGS) based solutions may reduce burden o...